Press release Read more about Excellent 2022 performance in a challenging environment 21% growth to €130.8m, of which 10% organic Confirmed pricing power: strong ability to pass on the increase in agricultural raw materials prices
Press release Read more about EDF: Information regarding the voting rights and shares (Article L.233-8-II of the French Commercial Code and 223-16 of the General Regulations of the “AMF”)
Press release Read more about Monthly information related to total number of voting rights and shares composing the share capital _January 31, 2023
Press release Read more about Reminder: Cyviz AS - Invitation to presentation of Q4 2022 financial results
Press release Read more about Oncodesign Precision Medicine Announces the Initiation of Phase I of its RIPK2 Inhibitor ODS-101, a New Therapeutic Agent for IBD